Page last updated: 2024-10-26

doxylamine and Acute Myelogenous Leukemia

doxylamine has been researched along with Acute Myelogenous Leukemia in 1 studies

Doxylamine: Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in PARKINSONISM.

Research Excerpts

ExcerptRelevanceReference
"81 and a dose-response relationship was noted (P = 0."2.66Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). ( Arthur, DC; Benjamin, D; Buckley, JD; Daigle, AE; Hammond, GD; Robison, LL; Wells, R, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robison, LL1
Buckley, JD1
Daigle, AE1
Wells, R1
Benjamin, D1
Arthur, DC1
Hammond, GD1

Trials

1 trial available for doxylamine and Acute Myelogenous Leukemia

ArticleYear
Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group).
    Cancer, 1989, May-15, Volume: 63, Issue:10

    Topics: Adolescent; Age Factors; Antiemetics; Child; Child, Preschool; Dicyclomine; Doxylamine; Drug Combina

1989